IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casdin Capital, LLC

Q4 2018 Holdings

Filed 2019-02-13 | 31 holdings | $124.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Codexis Inc(CDXS)COM192005106$33.8M2,025,00027.1%
Biolife Solutions Inc(BLFS)COM NEW09062W204$29.2M2,428,57123.4%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$25.9M355,00020.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$20.5M445,00016.4%
Beigene LTD(ONC)SPONSORED ADR07725L102$9.8M70,0007.9%
Caredx Inc(CDNA)COM14167L103$5.0M200,0004.0%
Loxo Oncology IncCOM548862101$50.4K360,0000.0%
Myokardia IncCOM62857M105$38.6K790,0000.0%
Blueprint Medicines Corp(2L9)COM09627Y109$34.5K640,0000.0%
Spark Therapeutics IncCOM84652J103$32.9K840,0000.0%
Bluebird BIO IncCOM09609G100$32.7K330,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$32.7K2,550,0000.0%
Sage Therapeutics Inc(SG7)COM78667J108$29.9K312,0000.0%
Invitae Corp(NVTA1EUR)COM46185L103$26.5K2,400,0000.0%
Genmark Diagnostics Inc(GNMK)COM372309104$18.5K3,815,0000.0%
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$18.3K860,0000.0%
Illumina Inc(ILMN)COM452327109$18.0K60,0000.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$16.4K150,0000.0%
Magenta Therapeutics IncCOM55910K108$15.1K2,643,3170.0%
Global Blood Therapeutics inCOM37890U108$14.4K350,0000.0%
Sangamo Therapeutics Inc(SGMO)COM800677106$12.4K1,080,0000.0%
Gritstone Oncology Inc(2JQ)COM39868T105$11.1K720,5860.0%
Evolent Health Inc(EVH)CL A30050B101$11.0K550,0000.0%
Editas Medicine Inc(EDIT)COM28106W103$10.9K480,0000.0%
Voyager Therapeutics Inc(VYGR)COM92915B106$10.6K1,128,0750.0%
Homology Medicines IncCOM438083107$7.8K350,0000.0%
Constellation Pharmceticls I(CNST)COM210373106$6.2K1,556,9980.0%
Ishares TR(IBB)NASDAQ BIOTECH464287556$5.8K60,0000.0%
Denali Therapeutics Inc(DNLI)COM24823R105$2.1K100,0000.0%
Quotient LTDSHSG73268107$2.0K325,0000.0%
Neon Therapeutics IncCOM64050Y100$1.3K263,3440.0%